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Cyclin-dependent kinase 5 regulates numerous
neuronal functions with its activator, p35. Under
neurotoxic conditions, p35 undergoes proteolytic
cleavage to liberate p25, which has been implicated
in various neurodegenerative diseases. Here, we
show that p25 is generated following neuronal activ-
ity under physiological conditions in a GluN2B- and
CaMKIIa-dependent manner. Moreover, we devel-
oped a knockin mouse model in which endogenous
p35 is replaced with a calpain-resistant mutant p35
(Dp35KI) to prevent p25 generation. The Dp35KI
mice exhibit impaired long-term depression and de-
fective memory extinction, likely mediated through
persistent GluA1 phosphorylation at Ser845. Finally,
crossing the Dp35KI mice with the 5XFAD mouse
model of Alzheimer’s disease (AD) resulted in an
amelioration of b-amyloid (Ab)-induced synaptic
depression and cognitive impairment. Together,
these results reveal a physiological role of p25 pro-
duction in synaptic plasticity and memory and
provide new insights into the function of p25 in
Ab-associated neurotoxicity and AD-like pathology.
INTRODUCTION
Cyclin-dependent kinase 5 (Cdk5) is a multifaceted serine/
threonine kinase that plays essential roles in various aspects of
brain development, including neuronal migration and positioning
(Chae et al., 1997; Gilmore et al., 1998), and dendritic spine
formation (Fu et al., 2007; Kim et al., 2006). In addition, Cdk5
phosphorylates a number of substrates at the presynaptic and486 Cell 157, 486–498, April 10, 2014 ª2014 Elsevier Inc.postsynaptic terminals of mature neurons, and mediates various
synaptic functions (Su and Tsai, 2011). Thus, themechanisms by
which Cdk5 activity is regulated to mediate these functions
deserve serious attention.
Conventionally, Cdk5 activity is thought to be governed by
its binding to its regulatory subunits p35 or p39, and mice
simultaneously deficient in both p35 and p39 recapitulate the
phenotypes of Cdk5 null mice (Ko et al., 2001). Interestingly,
Cdk5 is also activated through its association with p25, a pro-
teolytic fragment of p35 that is generated via its cleavage by
calpain, a calcium-dependent cysteine protease. p25 has a
longer half-life and a more diffuse subcellular distribution than
p35 (because the myristoylated portion of p35 resides in
the cleaved portion) (Patrick et al., 1999), and confers p25/
Cdk5 with distinct properties compared with p35/Cdk5.
Elevated levels of p25 have been documented upon exposure
to various neurotoxic stimuli, including oxidative stress and
b-amyloid (Ab) peptides (Lee et al., 2000b), and in the brain
of multiple Alzheimer’s disease (AD) mouse models (Crews
et al., 2011; Oakley et al., 2006; Otth et al., 2002). An increase
in p25 levels in postmortem AD brains has also been reported
(Patrick et al., 1999; Sadleir and Vassar, 2012; Swatton et al.,
2004), although other studies detected no such differences
(Engmann et al., 2011; Tandon et al., 2003; Yoo and Lubec,
2001). In addition, transgenic mice that overexpress p25 exhibit
various features of neurotoxicity, such as tau pathology, Ab
accumulation, astrogliosis, and profound memory impairment
(Su and Tsai, 2011). In contrast, transgenic mice with milder
p25 overexpression exhibit improved memory function (Angelo
et al., 2003). Together, these observations suggest that
p25 leads to aberrant Cdk5 activity that contributes to neurode-
generation. However, it remains to be determined whether
p25 generation is restricted to pathological conditions or is
also important for physiological neuronal functions. Further-
more, despite the elevation in p25 levels that occurs under
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Figure 1. Activity-Induced p25 Generation
in Hippocampus via NMDAR and CaMKIIa
(A) Primary cultured neurons were treated with
NMDA (100 mM for 5 min) or glycine (200 mM for
3 min), and further incubated in conditioned media
for the specified times.
(B) Acute hippocampal slices were treated with
NMDA (50 mM for 5 min) or glycine (100 mM for
3 min), followed by ACSF for 15 min. Right: the bar
graph represents relative immunoreactivity of p25/
p35 compared with control (n = 3 per group).
(C) WT mice were sacrificed after contextual FC
(0.8 mA shock for 2 s) and hippocampi were iso-
lated for immunoblotting (n = 6 per group).
(D) Pretreatment of hippocampal slices with the
AMPAR antagonist CNQX (10 mM), the NMDAR
antagonist APV (50 mM), the GluN2A subunit-
specific inhibitor NVP-AAM077 (0.5 mM), the
GluN2B subunit-specific inhibitor ifenprodil
(10 mM), the CaMKIIa inhibitor KN-62 (10 mM), or
the calpain inhibitor calpeptin (10 mM) followed by
NMDA treatment (n = 3–4 per group).
(E) PSD fractions from WT hippocampus were
subjected to the IP with an anti-p35 or anti-
CaMKIIa antibody. The asterisk represents a
nonspecific background band.
*p < 0.05, **p < 0.01, ***p < 0.001 by Student’s
t test; error bars ± SEM. See also Figure S1.various neurotoxic conditions, the specific contribution of p25,
if any, to AD-like pathologies, including cognitive impairment,
remain obscure.
RESULTS
Neuronal Activity Regulates p25 Generation
To address whether p25 is generated under physiological
conditions, we treated cultured primary neurons with either
N-methyl-D-aspartate (NMDA) to induce chemical long-term
depression (LTD) (Lee et al., 1998) or glycine to induce chemical
long-term potentiation (LTP) (Lu et al., 2001). p25 genera-
tion was evident as early as 5 min following treatment and
persisted for more than 30 min (Figure 1A). In addition, acute
hippocampal slices from wild-type (WT) mice showed a nearly
2-fold increase in p25 levels following glycine or NMDA treat-
ment (Figure 1B). To determine whether p25 is produced
following hippocampus-dependent learning, we harvested hip-
pocampal tissue following contextual fear conditioning (FC)
training, and observed markedly increased p25 levels in the
FC group compared with the naive group (Figure 1C). In addi-
tion, reexposure to the training chamber 24 hr after the training
increased p25 levels (Figure S1A available online). These results
indicate that p25 is generated in the brain in an activity-depen-
dent manner.Cell 157, 486–4p35 Is Cleaved by Calpain in an
NMDAR- and CaMKIIa-Dependent
Manner
In an effort to elaborate the mechanisms
that lead to p25 generation, we first used
calpeptin to inhibit calpain, which cleavesp35 to p25 following neurotoxic stimuli. NMDA treatment of acute
hippocampal slices in the presence of calpeptin substantially
reduced p25 levels, suggesting that calpain is required for activ-
ity-dependent p25 liberation (Figure 1D). Next, we blocked
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid recep-
tors (AMPARs) and NMDA receptors (NMDARs), which mainly
govern postsynaptic Ca2+ influx under physiological conditions
(Collingridge et al., 2004). Incubation with the NMDAR antago-
nist APV, but not the AMPAR antagonist CNQX, severely
diminished NMDA-induced p25 generation (Figure 1D). In
addition, inhibition of GluN2B, but not GluN2A (using ifenprodil
and NVP-AAM077, respectively), also led to reduced p25
levels (Figure 1D). The Ca2+/calmodulin kinase CaMKIIa, which
plays a prominent role in synaptic plasticity and memory forma-
tion, interacts with p35 in a Ca2+- and NMDAR-dependent
manner (Dhavan et al., 2002). Prompted by these observa-
tions, we treated acute hippocampal slices with the specific
CaMKIIa inhibitor, KN-62, and showed that this was sufficient
to abolish NMDA-induced p25 generation (Figure 1D). Finally,
immunoprecipitation (IP) experiments revealed that both
CaMKIIa and GluN2B interact with p35 in a complex that also
contains calpain 1 at the hippocampal postsynaptic density
(PSD) (Figures 1E and S1B). Together, these results suggest
a signaling cascade in which activation of NMDAR stimu-
lates calpain-mediated p35 cleavage and the liberation of p2598, April 10, 2014 ª2014 Elsevier Inc. 487
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Figure 2. Normal Learning but Impaired
Memory Extinction in Dp35KI Mice
(A) Strategy for generating the calpain-mediated,
cleavage-resistant p35 protein.
(B) Expression levels of p35 and Dp35 in the fore-
brain of WT and Dp35KI mice, respectively. The
asterisk represents a nonspecific background
band.
(C) IP-linked Cdk5 kinase assay was performed on
WT or Dp35KI brain lysates and normalized to WT
(n = 4 per group).
(D) p25 expression inWT and Dp35KI hippocampal
slices following NMDA or glycine treatment. Dp35
expression in Dp35KI hippocampus was con-
firmed by immunoblotting with an anti-HA anti-
body. The asterisk represents a nonspecific
background band.
(E) Basal movement behavior of WT (n = 9) and
Dp35KI (n = 8) mice during the habituation period
before FC.
(F) Fear memory extinction testing by daily re-
exposure to the conditioning chamber (repeated-
measures ANOVA).
(G) Swim speeds ofWT (n = 10) andDp35KI (n = 10)
mice during the water maze test.
(H) Escape latencies of WT and Dp35KI mice in the
Morris water maze test.
(I) Number of platform crossings by WT and
Dp35KI mice on the first probe test day.
(J) Number of platform crossings by WT and
Dp35KI mice during repeated probe trials
(repeated-measures ANOVA).
(K) Time spent byWT andDp35KImice in the target
or the opposite quadrant during repeated probe
trials (Student’s t test).
*p < 0.05; **p < 0.01; ***p < 0.001; error bars ±
SEM. See also Figures S2 and S3.from PSD (Figure S1C) in a GluN2B- and CaMKIIa-dependent
manner.
Generation of Cleavage-Resistant p35 Knockin Mice
To determine whether activity-induced p25 production plays a
physiological role, we developed a calpain cleavage-resistant488 Cell 157, 486–498, April 10, 2014 ª2014 Elsevier Inc.p35 protein in which six amino acid resi-
dues adjacent to the calpain-cleavage
site (D93–98; Lee et al., 2000b) were
deleted and the Ala residue at the cleav-
age sitewas replacedwith Leu (Figure 2A).
The cleavage resistance of the mutant
p35 (Dp35) was first verified in human
neuroblastoma cells treated with ionomy-
cin, a calcium ionophore (Figure S2A).
Notably, Dp35 showed no differences in
half-life, subcellular localization, or ca-
pacity to activate Cdk5 compared with
WT p35 (Figures S2B–S2D), indicating
that the cleavage resistance of the
Dp35 protein is successfully endowed
without altering other characteristics of
native p35.Given these properties of Dp35 in vitro, we developed a
knockin mouse in which the endogenous p35 is replaced with
Dp35 (Dp35KI; Figure S2E). The Dp35KI mice are viable and
fertile, and devoid of neurodevelopmental abnormalities (Fig-
ure S3A). The expression levels of Dp35 were similar to those
of p35 in brain lysates from WT mice, and Cdk5 activity was
comparable between the two groups (Figures 2B and 2C).
Importantly, there was no detectable p25 immunoreactivity in
hippocampal slices from Dp35KI mice following NMDA or
glycine treatment (Figure 2D), indicating that activity-dependent
p25 generation is absent in Dp35KI mice.
Dp35KI Mice Exhibit Normal Learning but Impaired
Memory Extinction
To investigate the role of activity-induced p25 generation in vivo,
we first performed a series of behavioral assays. An assessment
of overall exploratory activity in the open field test and anxiety in
the light-dark exploration test revealed no differences between
Dp35KI and WT mice (Figures S3B–S3H). We then performed
contextual FC to assess associative learning in the Dp35KI
mice. There was no significant difference in animal movement
in the conditioning chamber during the habituation period be-
tween the two groups (Figure 2E). During the context-depen-
dent memory test, the freezing behavior of Dp35KI mice was
comparable to that of WT mice, indicating normal associative
memory formation in the Dp35KI mice (day 2, Figure 2F). Sur-
prisingly, however, Dp35KI mice showed significantly higher
levels of freezing behavior on subsequent trials, indicative of
impaired memory extinction (Figure 2F). To further characterize
this memory phenotype, we employed the Morris water maze
test. We trained mice in the water maze for 8 days, and conduct-
ed probe tests on three consecutive days in order to examine
their extinction phenotype (Zhang et al., 2011). WT and
Dp35KI mice were similar in measures of swim speed, latency
in locating the platform, and the number of platform crossings
during the first probe trial, indicating no differences in either
learning or spatial memory (Figures 2G–2I). Probe trials re-
peated on subsequent days induced memory extinction in WT
mice, as evidenced by a significant decrease in the number of
platform crossings (Figure 2J), as well as a similar decrease in
amount of time spent in the target quadrants on probe trial
days 2 and 3 (Figure 2K). In contrast, the Dp35KI mice showed
increased crossing of the platform location (Figure 2J) and
continued to preferentially explore the target quadrant during
additional probe trials (Figure 2K). Altogether, these data
strongly suggest a role for p25 in memory extinction.
Dp35KI Mice Exhibit Normal Hippocampal LTP but
Impaired NMDAR-Dependent LTD
We next addressed the role of p25 generation in synaptic func-
tion by performing extracellular and intracellular recordings in
acute hippocampal slices from Dp35KI and WT mice. An
examination of the basal synaptic transmission (Figure 3A)
and the probability of presynaptic neurotransmitter release (as
determined by measuring paired-pulse facilitation (PPF) ratios;
Figure 3B) revealed no differences between Dp35KI and WT
slices. Similarly, whole-cell recordings of CA1 pyramidal neu-
rons showed no significant differences in either the frequency
or amplitude of miniature excitatory postsynaptic currents
(mEPSCs) or miniature inhibitory PSCs (mIPSCs) between
Dp35KI andWT slices (Figures 3C and 3D). Next, we investigated
synaptic plasticity at Schaffer collateral-CA1 synapses. In
Dp35KI hippocampal slices, LTP induced by theta-burst stimula-
tion (TBS) was comparable to WT levels (Figure 3E). However,the induction of NMDAR-dependent LTD by single-pulse low-
frequency stimulation (SP-LFS) was significantly impaired in
the Dp35KI mice (Figure 3F). We observed normal metabotropic
glutamate receptor (mGluR)-dependent LTD in Dp35KI hippo-
campal slices (Figure S4A). Furthermore, mGluR activation did
not induce p25 generation in WT hippocampus (Figure S4B).
These results indicate that activity-induced p25 is necessary
for NMDAR-dependent LTD at hippocampal synapses.
p25/Cdk5 Regulates AMPAR Endocytosis via PP1,
Calcineurin, and DARPP-32
Memory extinction and NMDAR-dependent LTD both require
AMPAR endocytosis, which is mediated by phosphatase-
dependent AMPAR dephosphorylation (Dalton et al., 2008;
Kim et al., 2007; Lee et al., 2000a). From our results thus far,
we reasoned that the p25/Cdk5 kinase might play a role in
LTD by facilitating AMPAR endocytosis. This was indeed shown
to be the case. First, a comparison of Cdk5 activity following
NMDA treatment revealed increased Cdk5 activity in hippocam-
pal slices fromWT, but not Dp35KI, mice (Figure 4A), suggesting
that NMDA-induced p25 generation increases Cdk5 activity in
the hippocampus. AMPAR endocytosis during LTD is associ-
ated with the phosphorylation of GluA1 at Ser845 and changes
in GluA1 surface levels (Lee et al., 2000a). Whereas NMDA
administration induced a robust reduction in GluA1 phospho-
(p)Ser845 and surface GluA1 levels in WT hippocampal slices,
no such changes were detected following NMDA treatment of
Dp35KI slices (Figure 4B). These results suggest that p25/
Cdk5 activity is essential for AMPAR dephosphorylation and
endocytosis.
To further delineate the mechanisms underlying this pro-
cess, we focused on two protein phosphatases that mediate
AMPAR dephosphorylation during LTD formation: protein phos-
phatase-1 (PP1) and calcineurin (PP2B) (Mulkey et al., 1993,
1994). Although there was no difference in the levels of PP1
and calcineurin either basally or following NMDA treatment be-
tween WT and Dp35KI hippocampus (Figure 4D and data not
shown), phosphatase assays revealed that NMDA administra-
tion significantly increased the activity of both PP1 and calci-
neurin in WT, but not Dp35KI, hippocampus (Figure 4E). To
test whether the inhibition of p25 generation alters NMDAR-
dependent calcium influx, we conducted calcium imaging in
primary cultured neurons from WT or Dp35KI mice. We
observed no differences in NMDA-induced intracellular calcium
changes between the two groups (Figure S4C), suggesting that
the impaired calcineurin activation evident in the Dp35KI mice
is unlikely to result from altered NMDAR-dependent calcium
influx.
The dopamine and cyclic AMP-regulated phosphoprotein
DARPP-32 is a well-established negative regulator of PP1 in
the dopaminergic system (Hemmings et al., 1984). Phosphoryla-
tion at Thr34 by protein kinase A (PKA) activates DARPP-32,
whereas calcineurin dephosphorylates this residue (Halpain
et al., 1990). Interestingly, Cdk5 is known to phosphorylate
DARPP-32 at Thr75 and block its activation (Bibb et al., 1999).
Thus, we speculated that p25/Cdk5 might regulate DARPP-32
and, in turn, PP1 activity in the hippocampus. We first confirmed
that DARPP-32 is expressed in the hippocampus, and found thatCell 157, 486–498, April 10, 2014 ª2014 Elsevier Inc. 489
Figure 3. Normal Synaptic Transmission
and LTP, but Impaired LTD, in Dp35KI Hip-
pocampus
(A) The synaptic input-output relationship was
obtained by plotting the slopes of evoked fEPSPs
against fiber-volley amplitude. WT, n = 7 slices
from 4 mice; Dp35KI, n = 8 slices from 4 mice.
Scale bars, 0.5 mV and 20 ms.
(B) The ratios of paired-pulse facilitation (second
fEPSP slope/first fEPSP slope) were plotted as a
function of interstimulus interval (ms). WT, n = 6
slices from 3 mice; Dp35KI, n = 5 slices from 3
mice. Scale bars, 0.5 mV and 200 ms.
(C) mEPSC amplitude and frequency in CA1
pyramidal neurons of WT and Dp35KI mice
(WT, amplitude: 10.5% ± 1.1%, frequency:
1.0% ± 0.3%, 12 slices from 3 mice; Dp35KI,
amplitude: 10.2% ± 0.5%, frequency: 0.90% ±
0.3%, 11 slices from 3 mice). Scale bars, 10 pA
and 200 ms.
(D) mIPSC amplitude and frequency in CA1
pyramidal neurons of WT and Dp35KI mice (WT,
amplitude: 29.0% ± 1.8%, frequency: 2.5% ±
0.3%, 13 slices from 3 mice; Dp35KI, amplitude:
25.9% ± 1.3%, frequency: 2.2% ± 0.4%, 11 slices
from 3 mice). Scale bars, 10 pA and 200 ms.
(E) LTP was induced by 33 TBS at the Schaffer
collateral-CA1 synapses of WT or Dp35KI mice.
Sample traces represent fEPSPs at 1 min before
(gray) and 1 hr after (black) TBS. Scale bars,
0.5 mV and 10 ms. Right: the magnitude of LTP
was calculated by comparing the average slopes
of fEPSPs during the last 10 min of recordings with
those recorded before stimulation (WT: 137.3% ±
11.2%, 9 slices from 4 mice; Dp35KI: 136.1% ±
10.0%, 6 slices from 3 mice).
(F) LTD was induced by SP-LFS at the Schaffer
collateral-CA1 synapses of WT or Dp35KI mice.
Sample traces represent fEPSPs at 1 min
before (gray) and 1 hr after (black) SP-LFS.
Scale bars, 0.5 mV and 10 ms. Right: the
magnitude of LTD was calculated by comparing
the average slopes of fEPSPs during the last
10 min of recordings with those recorded before
stimulation (WT: 75.0% ± 5.3%, 7 slices from 4
mice; Dp35KI: 96.1% ± 2.3%, 8 slices from 4
mice).
**p < 0.01 by Student’s t test; error bars ± SEM.
See also Figure S4.its levels were comparable between Dp35KI and WT mice (Fig-
ure S4D). Interestingly, the Cdk5f/f/T29 mouse, in which Cdk5
is deleted in CA1 (Guan et al., 2011), exhibits markedly reduced
levels of DARPP-32 pThr75 in this region (Figure 4F), suggest-
ing that DARPP-32 is a Cdk5 substrate in the hippocampus.
Next, we found that NMDA administration caused a signifi-
cant upregulation of DARPP-32 pThr75 in WT hippocampal
slices, whereas no such changes were detectable in the
Dp35KI hippocampus (Figure 4G). Taken together, these results
unveil a novel physiological function for p25/Cdk5 in AMPAR
endocytosis that is likely mediated through its inhibition of490 Cell 157, 486–498, April 10, 2014 ª2014 Elsevier Inc.DARPP-32 and the activation of PP1 and calcineurin in response
to neuronal activation.
p25/Cdk5Regulates Ab-Induced Synaptic Depression in
the Hippocampus
Many lines of evidence indicate that Ab increases intracellular
Ca2+ levels and subsequently induces hippocampal synaptic
depression via the activity of GluN2B and calcineurin (Kamenetz
et al., 2003; Kuchibhotla et al., 2008; Li et al., 2011). It has also
been reported that incubation of cultured neurons with Ab in-
duces p25 generation (Lee et al., 2000b; Yang et al., 2008) and
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Figure 4. p25/Cdk5 Mediates NMDA-
Induced AMPAR Endocytosis by Inhibiting
DARPP-32 and Activating PP1 and Calci-
neurin at Hippocampal Synapses
(A) NMDA was applied to acute hippocampal slices
for 5 min, followed by ACSF for an additional 5 min.
Cdk5kinaseassaywasperformedonWTorDp35KI
hippocampal lysates, and Cdk5 activity was nor-
malized to each untreated control (n = 4 per group).
(B) NMDA was applied to acute hippocampal sli-
ces and the slices were then allowed to recover for
30 min. Biotinylation assay was performed to
measure surface/total levels of GluA1. Bottom: the
relative immunoreactivity of surface GluA1/total
GluA1 levels were normalized to each untreated
control (n = 3 per group).
(C) NMDA was applied to acute hippocampal sli-
ces and the slices were allowed to recover for
15 min before being lysed for immunoblotting.
Bottom: the relative immunoreactivity of GluA1
pSer845/total GluA1 was normalized to each
untreated control (n = 6 per group).
(D) The expression levels of PP1 and calcineurin
before and after NMDA treatment were examined
by immunoblotting, and relative immunoreactivity
of PP1 or calcineurin was normalized to each
untreated control (n = 3 per group).
(E) NMDA was applied to acute hippocampal
slices and the slices were allowed to recover for
5 min. Protein phosphatase assays were per-
formed on WT or Dp35KI hippocampal lysates,
and PP1 and calcineurin activity was normalized
to WT control (n = 3 per group).
(F) Immunoblot analysis was performed with an
anti-DARPP-32 pThr75 antibody using the lysates
from hippocampal CA1 of Cdk5f/f/T29 mice. An
anti-Cdk5 antibody was used for confirmation of
Cdk5 knockout.
(G) NMDA was applied to acute hippocampal sli-
ces and the slices were allowed to recover for
5 min before being lysed for immunoblotting.
Right: the relative immunoreactivity of DARPP-32
pThr75/total DARPP-32 was normalized to each
control (n = 4 per group).
*p < 0.05, **p < 0.01 by Student’s t test; error
bars ± SEM. See also Figure S4.that p25 levels are upregulated in familial AD mouse models
(Crews et al., 2011; Oakley et al., 2006; Otth et al., 2002). We
showed that p25 generation impacts memory extinction and
synaptic plasticity under physiological conditions; thus, we
reasoned that a chronic upregulation of p25 in response to toxic
stimuli might dysregulate these processes. To test whether p25
plays a role in Ab-induced synaptic depression, we examined
oligomeric Ab1-42-induced synaptic depression in hippocampal
slices from Dp35KI andWTmice. As previously reported (Kame-
netz et al., 2003), incubation of hippocampal slices in Ab gradu-
ally reduced the field excitatory postsynaptic potential (fEPSP)
slope in theWT slices. In contrast, no such changeswere detect-
able in Dp35KI hippocampal slices (Figure 5A). Additionally, we
verified that Ab treatment increased p25 levels in hippocampal
slices fromWT, but notDp35KI, mice (Figure 5B). Thus, p25 gen-
eration is essential for Ab-induced synaptic depression in the
hippocampus.p25-Mediated DARPP-32 Inhibition and AMPAR
Dephosphorylation Are Observed in the 5XFAD Mouse
The resistance to Ab-induced synaptic depression apparent in
the Dp35KI mice led us to question whether p25/Cdk5 activity
mediates synaptic dysfunction in the brain of an AD mouse
model that is characterized by Ab deposition. We crossed the
Dp35KI mouse with the 5XFADmouse, a well-established model
that harbors three amyloid precursor protein (APP) and two
presenilin 1 (PSEN1) mutations that are causally linked to familial
AD (Oakley et al., 2006). Hippocampal lysates from 5XFAD mice
showed increased Cdk5 activity compared with either WT or
Dp35KI mice. In contrast, Cdk5 activity was significantly attenu-
ated in the 5XFAD;Dp35KI compound mice, suggesting that the
elevation of Cdk5 activity in the 5XFAD hippocampus is p25
dependent (Figure 5C). From our previous observations, we
hypothesized that alterations in p25/Cdk5-mediated DARPP-
32 phosphorylation and AMPAR endocytosis may contribute toCell 157, 486–498, April 10, 2014 ª2014 Elsevier Inc. 491
Figure 5. Prevention of Ab-Induced Synap-
tic Depression and Excessive DARPP-32 In-
hibition and AMPAR Dephosphorylation in
5XFAD Mouse Brain by Blockade of p25
Generation
(A) Stable basal synaptic transmission was re-
corded from WT or Dp35KI hippocampal slices for
at least 15 min, followed by incubation in Ab1-42
(0.2 mM) for 40 min. Scale bars, 0.5 mV and 10 ms.
Sample traces represent fEPSPs at 1 min before
(gray) and 40 min after (black) Ab1-42 treatment.
Right: the magnitude of Ab1-42-induced depression
was calculated by comparing the average slopes of
fEPSPs during the last 10 min of recordings with
thoseobtainedbeforeAb1-42 treatment (WT:8.8%±
3.3%,7 slices from3mice;Dp35KI:1.2%± 2.4%,
6 slices from 3 mice). Student’s t test.
(B) Levels of p25 in WT and Dp35KI hippocampus
after incubation with Ab1-42. Dp35 expression in
Dp35KI hippocampus was confirmed by immu-
noblotting with an anti-HA antibody. The asterisk
represents a nonspecific background band. Right:
the bar graph represents relative immunoreac-
tivity of p25/p35 compared with the WT untreated
group (n = 5 per group; Student’s t test).
(C) IP-linked Cdk5 kinase assays were performed
on WT, 5XFAD, Dp35KI, or 5XFAD;Dp35KI hip-
pocampal lysates (n = 5 per group).
(D) The relative immunoreactivity of DARPP-32 pThr75/total DARPP-32 was normalized to WT (n = 4–6 per group; p < 0.01 by ANOVA).
(E) The relative immunoreactivity of GluA1 pSer845/total GluA1 was normalized to WT (n = 3 per group; p < 0.01 by ANOVA).
*p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test or Tukey’s post hoc analysis; error bars ± SEM. See also Figure S5.the synaptic defects that accrue in 5XFAD brains. Interestingly,
we observed increased levels of DARPP-32 pThr75 and
decreased GluA1 pSer845 levels in 5XFAD hippocampus
compared with either WT or Dp35KI mice. However, consistent
with attenuated Cdk5 activity, the levels of DARPP-32 pThr75
and GluA1 pSer845 in 5XFAD;Dp35KI hippocampus were
comparable to those in WT and Dp35KI mice (Figures 5D and
5E). Fibrillar Ab deposition in the hippocampus of 5XFAD mice
becomes apparent at 3–4 months of age (Oakley et al., 2006;
Figure S5A). To address whether DARPP-32 and GluA1 phos-
phorylation are altered prior to Ab deposition in hippocampus,
we examined hippocampi from 2-month-old WT, 5XFAD,
Dp35KI, and 5XFAD;Dp35KI mice, and found no differences in
either the DARPP-32 pThr75 or GluA1 pSer845 levels (Fig-
ure S5B). Interestingly, the p25 levels in the hippocampi of
5XFAD mice were comparable to those in the WT at this age.
Altogether, these data suggest that Ab deposition induces
p25 generation and leads to DARPP-32 inhibition and GluA1
Ser845 dephosphorylation.
Blockade of p25 Generation Rescues Synaptic
Dysfunction and Cognitive Impairment in 5XFAD Mice
To further determine the contribution of aberrant p25 generation
to synaptic dysfunction and cognitive impairment in the 5XFAD
mice, we examined synaptic physiology at Schaffer collateral-
CA1 synapses. We observed reduced input-output ratios in
both 5XFAD and 5XFAD;Dp35KI hippocampi compared with
either WT or Dp35KI mice (Figure S6A), indicating a decreased
basal synaptic transmission phenotype in these mice that is
not altered by the absence of p25. We previously showed that492 Cell 157, 486–498, April 10, 2014 ª2014 Elsevier Inc.excessive GluA1 Ser845 dephosphorylation in the 5XFAD hippo-
campus, associated with decreased surface levels of AMPARs,
is attenuated in 5XFAD;Dp35KI compound mice (Figure 5E);
thus, it is possible that other factors may underlie impaired basal
synaptic transmission in the 5XFAD mice in a p25-independent
manner. However, we found that the impaired LTP that is char-
acteristic of the 5XFAD hippocampus (Chen et al., 2012; Kimura
and Ohno, 2009) was restored toWT levels in the 5XFAD;Dp35KI
compound mice (Figure 6A). Similarly, in behavioral experi-
ments, we found that the established 5XFAD phenotypes of
reduced anxiety (Jawhar et al., 2012) and poor cognitive perfor-
mance in the novel-object recognition and contextual and cued
FC paradigms were all suppressed in 5XFAD;Dp35KI compound
mice (Figures 6B and 6C, and S6C).
p25 Inhibition Attenuates HDAC2 Upregulation, Glial
Activation, and Ab Accumulation in the 5XFAD Mouse
Brain
Our results prompted us to determine the specific effects of
Ab-induced p25 generation on various pathological hallmarks
of AD. Histone deacetylase 2 (HDAC2) is a Class I HDAC that
negatively regulates the expression of genes associated with
learning andmemory (Guan et al., 2009), which we previously re-
ported to be a negative regulator of learning and memory that is
induced upon aberrant Cdk5 activity and in the AD brain (Gräff
et al., 2012). Whereas elevated HDAC2 levels and a concomitant
decrease in histone H3 acetylation at Lys 9/14 (AcH3; H3K9/14)
were detected in CA1 of 6-month-old 5XFAD mice, these
changes were significantly attenuated in 5XFAD;Dp35KI mice
(Figure 7A).
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Figure 6. Inhibition of p25 Generation Res-
cues Synaptic Dysfunction and Cognitive
Impairment in 5XFAD Mice
(A) LTP was induced by 43 TBS at Schaffer
collateral-CA1 synapses. Sample traces represent
fEPSPs at 1 min before (gray) and 1 hr after (black)
TBS. Scale bars, 0.5 mV and 10 ms. Right: the
magnitude of LTP was calculated by comparing
the average slopes of fEPSPs during the last
10 min of recordings with those recorded before
stimulation. WT: 146.0% ± 5.1%, 8 slices from
5 mice; 5XFAD: 125.2% ± 8.1%, 7 slices from 5
mice; Dp35KI: 157.0% ± 10.1%, 5 slices from 3
mice; 5XFAD;Dp35KI: 156.8% ± 5.9%, 5 slices
from 3 mice, p < 0.01 by ANOVA.
(B) Novel-object test with WT, Dp35KI, 5XFAD,
and 5XFAD;Dp35KI mice. Right: discrimination
index for novel-object recognition (WT: 61.8 ± 2.8,
n = 8; 5XFAD: 45.9 ± 3.5, n = 7; Dp35KI: 61.9 ± 2.8,
n = 6; 5XFAD;Dp35KI: 66.6 ± 1.3, n = 9, p < 0.001
by ANOVA).
(C) Contextual and cued FC tests withWT,Dp35KI,
5XFAD, and 5XFAD;Dp35KI mice. Left: contextual
FC (WT: 65.6% ± 6.4%, n = 10; 5XFAD: 33.3% ±
7.6%, n = 12; Dp35KI: 50.0% ± 4.7%, n = 11;
5XFAD;Dp35KI: 72.2% ± 7.0%, n = 7, p < 0.05 by
ANOVA). Right: cued FC (WT: 75.0% ± 5.0%,
n = 10; 5XFAD: 44.9% ± 8.3%, n = 12; Dp35KI:
71.2% ± 3.9%, n = 11; 5XFAD;Dp35KI: 90.5% ±
3.1%, n = 7, p < 0.01 by ANOVA).
xp = 0.08, *p < 0.05, **p < 0.01, ***p < 0.001 by
Tukey’s post hoc analysis; error bars ± SEM. See
also Figure S6.Similarly, an increase in reactive astrocytes and activated
microglia in the 5XFAD mice hippocampus, a major pathological
feature of theADbrain (Perry et al., 2010;Verkhratsky et al., 2010),
was attenuated in the 5XFAD;Dp35KI mice (Figures 7B and 7C).
Moreover, although the mRNA levels of cytokines or chemokines
such as TNF-a, Il-1b, and MIP-1a were elevated in the 5XFAD
mice, they were significantly reduced in the 5XFAD;Dp35KI
mice (Figure S7A). These results suggest that p25 generation
contributes substantially to these AD-related pathologies.
In this work, we observed that Ab stimulates the accumulation
of p25; however, the formation of p25 is also known to upregu-
late b-secretase 1 (BACE1) (Cruz et al., 2006; Wen et al.,
2008). An upregulation of BACE1 in 5XFAD mice was reported
previously (Zhao et al., 2007). This increase in BACE1 levels in
the 5XFAD brain was suppressed in the absence of p25 genera-
tion in 5XFAD;Dp35KI mice (Figure 7D). Finally, we observed
modest but significant reductions in plaque load and size in the
hippocampus of 5XFAD;Dp35KI mice compared with 5XFAD
mice (Figure 7E). Furthermore, the levels of Ab1-42 and Ab1-40
were reduced by 20%–30% in the hippocampus of 5XFAD;
Dp35KI mice compared with 5XFAD mice (Figure 7F).
DISCUSSION
In this study, our use of a mouse model that specifically pre-
cludes the generation of the Cdk5-activating peptide, p25,
allowed us to delineate both the physiological and pathological
consequences of p25 generation. Our results show that p25functions as an integral component of synaptic plasticity, and
that blockade of p25 generation impairs hippocampal LTD and
memory extinction. Furthermore, we provide multiple lines of
evidence demonstrating that chronic p25 generation caused
by Ab induces persistent synaptic depression, impaired synaptic
plasticity, and reduced cognitive capacity, and thereby contrib-
utes to the development of AD-like pathologies.
Activity-Induced p25 Regulates LTD and Memory
Extinction
We show that diverse physiological stimuli and learning tasks
induce p25 formation in a GluN2B- and CaMKIIa-dependent
manner, and that activity-induced p25/Cdk5 specifically medi-
ates hippocampal LTD, but not LTP. These findings are consis-
tent with the observation that p35-deficient mice display normal
LTP but impaired LTD at hippocampal synapses (Ohshima et al.,
2005). Interestingly, p25 generation and elevated Cdk5 activity
were also detected following glycine-induced chemical LTP in
hippocampal slices from WT mice, and a similar increase in
Cdk5 activity was observed in the absence of p25 generation
in Dp35KI mice (Figure 1B and data not shown). These observa-
tions, together with the findings of normal LTP in the Dp35KI hip-
pocampus (Figure 3E), indicate that p25 production may not be
necessary for this form of synaptic plasticity. Perhaps this kind of
stimulation increases the interaction of Cdk5 and p35 (Dhavan
et al., 2002), or increases Cdk5 phosphorylation at Tyr15 (Zuker-
berg et al., 2000), which upregulates Cdk5 activity independently
of p25 generation. Nevertheless, it is interesting that p25Cell 157, 486–498, April 10, 2014 ª2014 Elsevier Inc. 493
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Figure 7. Inhibition of p25 Generation Attenuates Elevated HDAC2 Levels, Glial Activation, and Ab Accumulation in 5XFAD Mice
(A) Immunohistochemistry with anti-HDAC2 and anti-acetylated H3K9/14 (AcH3) antibodies in hippocampal CA1 of WT, Dp35KI, 5XFAD, and 5XFAD;Dp35KI
mice. Scale bar, 20 mm. Right: bar graphs represent the relative immunoreactivity of HDAC2 and AcH3 normalized toWT (n = 10–14 slices from 3mice per group;
p < 0.001 by ANOVA).
(B) Relative immunoreactivity of GFAP in hippocampus ofWT,Dp35KI, 5XFAD, and 5XFAD;Dp35KImice normalized toWT (n = 4 per group; p < 0.001 by ANOVA).
(C) Relative immunoreactivity of Iba-1 in the hippocampus of WT, Dp35KI, 5XFAD, and 5XFAD;Dp35KI mice normalized to WT (n = 4 per group; p < 0.05 by
ANOVA).
(D) Relative immunoreactivity of BACE1 in the hippocampus of WT, Dp35KI, 5XFAD, and 5XFAD;Dp35KI mice normalized to WT (n = 5 per group; p < 0.05 by
ANOVA).
(legend continued on next page)
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generation is induced by LTP protocols but is not involved in LTP
induction. Memory extinction has been often considered to
involve a decay of preexisting memory, caused by the degrada-
tion of memory-related molecules (Lee et al., 2008). However,
recent studies have raised the possibility that extinction could
be an active process that is mediated bymolecules induced dur-
ing learning processes (Shuai et al., 2010; Tronson et al., 2012).
Interestingly, inhibition of either NMDARs or CaMKIIa in the hip-
pocampus was shown to impair the extinction of conditioned
fear memory (Szapiro et al., 2003). Consistent with these find-
ings, blocking p25 generation specifically impairs memory
extinction, but not memory acquisition itself (Figures 2F, 2J,
and 2K). Thus, learning-induced p25 is specifically required for
extinction learning.
p25/Cdk5 Regulates NMDA-Induced AMPAR
Endocytosis by Inhibiting DARPP-32 and Activating
Calcineurin in the Hippocampus
We show that the blockade of p25 generation compromises
NMDA-induced AMPAR dephosphorylation and subsequent
AMPAR endocytosis (Figures 4B and 4C). It is known that activa-
tion of NMDARs negatively impacts DARPP-32 by inducing its
dephosphorylation in the striatum (Halpain et al., 1990). Here,
we identify DARPP-32 as the relevant Cdk5 substrate in the hip-
pocampus (Figure 4F). We show that p25/Cdk5 phosphorylates
DARPP-32 at Thr75 following NMDA treatment (Figure 4G),
which correlates with an increase in PP1 activity (Figure 4E),
although we cannot rule out the possibility that other PP1 inhib-
itor proteins, such as PP1 inhibitor-1, could also be regulated by
p25/Cdk5, as previously speculated (Etkin et al., 2006). In
addition to the regulation of DARPP-32 and PP1 activity, calci-
neurin activation following NMDA treatment is also significantly
impaired in the Dp35KI mouse hippocampus (Figure 4E). It is
presently unclear how activity-induced p25 regulates calcineurin
activity at hippocampal synapses. Previous studies have shown
that caspase-3 activity is increased by NMDAR activation, and
that caspase-3 knockout mice display impaired hippocampal
LTD but normal LTP (Li et al., 2010). Furthermore, it was shown
that p25/Cdk5 increases caspase-3 activity (Cruz et al., 2003),
and activated caspase-3 induces proteolytic cleavage of calci-
neurin, thereby increasing its catalytic activity (Mukerjee et al.,
2000). In the ADmouse brain, increased caspase-3 activity leads
to dephosphorylation of GluA1 Ser845 through the activation of
calcineurin (D’Amelio et al., 2011). Importantly, Ab-induced
caspase-3 activation is significantly reduced in Dp35KI neurons
compared with WT neurons (Figure S7B). These data suggest
that p25/Cdk5 regulates calcineurin activity via caspase-3.
p25: A Link between Ab and AD-Like Pathologies
Our study demonstrates that physiological neuronal activity re-
sults in the generation of p25 and that the resultant p25/Cdk5 is(E) Immunohistochemistry with an anti-4G8 antibody in hippocampal CA1 of W
number of Ab plaques/mm2 in hippocampuswas quantified and normalized to 5XF
mice (n = 21–24 slices from 7 mice per group; Student’s t test).
(F) Hippocampal Ab1-42 and Ab1-40 levels were measured by ELISA and norma
measurement; Student’s t test).
*p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test or Tukey’s post hoc analysnecessary for synaptic depression. As previously speculated
(KimandRyan, 2010;Mitra et al., 2012;Seeburg et al., 2008), acti-
vation of Cdk5 by p25 under these conditions may constitute a
homeostatic mechanism that is required to prevent hyperactivity
in neuronal networks. Interestingly, a number of reports have
described that neuronal activity correlates with Ab production
(Buckner et al., 2005; Cirrito et al., 2005; Kamenetz et al., 2003).
It is also known that p25 overexpression increases Ab levels
in vivo through a mechanism involving BACE1 (Cruz et al.,
2006; Wen et al., 2008). Together, these observations suggest
that a feed-forward relationship may exist between p25 and Ab
generation,wherein activity-inducedp25generationnot onlypar-
ticipates in themaintenance of brain activity but also upregulates
Ab levels. These elevated Ab levels then further increase p25.
p25/Cdk5 Contributes to Ab-Induced Synaptic
Depression and AD-Like Pathologies
A key finding of the current study is that Ab-induced synaptic
depression at hippocampal synapses is regulated by p25 (Fig-
ure 5A). It has been suggested that Ab facilitates LTD by inhibit-
ing glutamate uptake (Li et al., 2011). Interestingly, we observed
increased p25 levels in WT hippocampal slices following inhibi-
tion of glutamate uptake (Figure S7C). Because of the adverse
effects of p25 in neurons, many studies have focused on inhibit-
ing p25 using Cdk5 antagonists or truncated peptides derived
from p35 (Kesavapany et al., 2007; Su and Tsai, 2011). Although
aberrant Cdk5 activity elicited by p25 may be suppressed under
these conditions, it is unclear whether these effects are specific
to p25/Cdk5, or whether p35/Cdk5 activity may also be affected.
To delineate the precise role of p25/Cdk5 in a mouse model of
AD, we took advantage of Dp35KI mice, thereby blocking the
generation of p25 in 5XFAD mice, which were previously shown
to exhibit elevated p25 levels at a relatively young age (Oakley
et al., 2006). We show that the phenotypes of impaired LTP
and cognitive deficits were completely suppressed by blocking
p25 production in these mice (Figures 6A–6C). Further, the in-
creases in astrocyte and microglial activation, proinflammatory
cytokines, and HDAC2 expression observed in the 5XFAD
mice were markedly reduced in the absence of p25 accumula-
tion (Figures 7A–7C and S7A). Finally, elevated levels of Ab42/
40, as well as BACE1, were reduced in the 5XFAD mice when
p25 generation was blocked (Figures 7D and 7F). These results
strongly support the notion that p25 accumulation plays an
important role in AD pathogenesis and that inhibition of p25/
Cdk5 can potentially mitigate AD-related pathologies and cogni-
tive abnormalities.
EXPERIMENTAL PROCEDURES
See Extended Experimental Procedures for additional details regarding the
materials and methods used in this work.T, Dp35KI, 5XFAD, and 5XFAD;Dp35KI mice. Scale bar, 100 mm. Middle: the
ADmice. Right: the size of Ab plaques wasmeasured and normalized to 5XFAD
lized to 5XFAD (n = 6–7 per group for Ab1-42, and n = 3 per group for Ab1-40
is; error bars ± SEM. See also Figure S7.
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Animals
All experiments were performed according to the Guide for the Care and Use
of Laboratory Animals and were approved by the National Institutes of Health
and the Committee on Animal Care at the Massachusetts Institute of Technol-
ogy. 5XFAD transgenic mice were obtained from The Jackson Laboratory.
Primary Neuronal Cultures
Cortical and hippocampal cultures were prepared from embryonic day 15
(E15) and E16 C57BL/6 mice, and experiments were performed at 14–
16 days in vitro (DIV).
Immunoblot Analysis
Primary neurons were lysed or hippocampus was homogenized, and the
same quantities of lysates were subjected to SDS-PAGE and proved with
the indicated antibodies. All of the antibodies used in this study are listed in
Table S1.
CoIP Study
PSD fractions were prepared as previously described with somemodifications
(Carlin et al., 1980). IP from PSD fractions was performed by incubating
the lysates with 1 mg of the indicated antibodies overnight at 4C. Protein
A sepharose beads were then added and allowed to rock for 2 hr at 4C.
The beads were then washed three to five times and immunocomplexes
were eluted by addition of sample buffer and boiling, and analyzed by
SDS-PAGE.
DNA Constructs
All of the primers that were used to either generate or sequence constructs are
listed in Table S2.
IP-Linked Cdk5 Kinase Assays
Whole hippocampus or NMDA/Gly-treated hippocampal slices were lysed and
incubated with anti-Cdk5 antibody for 1 hr at 4C. The active Cdk5 complex
was isolated by incubation with protein A sepharose beads, and then the
immunoprecipitate was subjected to a Cdk5 kinase assay using histone H1
peptide (PKTPKKAKKL) as a substrate. Once a reaction mixture containing
(mM) 20 MOPS (pH 7.2), 5 MgCl2, 0.5 H1 peptide, 0.1 ATP, and 2.5 mCi
g-32ATP was added, the reaction continued for 20 min at room temperature,
and was halted by placing samples on ice for 5 min. Supernatants were
spotted on P-cellulose discs, washed in 0.3% phosphoric acid, and counted
in a liquid scintillation counter.
Generation of the Dp35-3xHA Knockin Mouse
For details regarding the generation of the Dp35-3xHA knockin mouse, see
Extended Experimental Procedures.
Biotinylation Assay
Hippocampal slices were incubated in ice-cold artificial cerebrospinal fluid
(ACSF) containing 2 mg/ml biotin (EZ-Link Sulfo-NHS-Biotin; Pierce) for
10 min, and then washed five times with Tris-buffered saline and homogenized
with ice-cold IP buffer containing (mM) 20 Na3PO4, 150 NaCl, 10 EDTA, 10
EGTA, 10 Na4P2O7, 50 NaF and 1 Na3VO4, and 1% Triton X-100 at pH 7.4.
Lysates were mixed with Neutravidin slurry (1:1 in 1% Triton X-100 IPB) and
rotated for 2 hr at 4C. Some homogenates were used to measure the total
GluA1 level. The Neutravidin beads were isolated by brief centrifugation at
1,0003 g and biotinylated surface proteins were eluted by addition of sample
buffer and boiling, and analyzed by SDS-PAGE.
Protein Phosphatase Assay
Hippocampal lysates were immunoprecipitated with anti-PP1 or anti-calci-
neurin antibody overnight at 4C, and then incubatedwithProtein A-Sepharose
beads for another 2 hr. The immunoprecipitates were washed three times with
lysis buffer, resuspended with assay buffer, and PP1 or calcineurin activity
was measured using the fluorescence-based RediPlate 96 EnzChek serine/
threonine phosphatase assay kit (Molecular Probes).496 Cell 157, 486–498, April 10, 2014 ª2014 Elsevier Inc.Immunohistochemistry
Animals were transcardially perfused with 4% paraformaldehyde in PBS under
anesthesia (2:1 of ketamine/xylazine), and brains were sectioned at 40 mm
thickness with a Leica VT1000S vibratome (Leica). Slices were permeabilized
with blocking solution containing 0.1% Triton X-100, 10% donkey serum, and
2% BSA in PBS for 1 hr at room temperature, and then incubated with indi-
cated antibodies overnight at 4C. The following day, slices were incubated
with fluorescently conjugated secondary antibodies (Molecular Probes) for
1 hr at room temperature, and nuclei were stained with Hoechst 33342
(Invitrogen).
ELISA
Hippocampi were isolated from 7- to 9-month-old females, lysed with 5 M
guanidine/50 mM Tris HCl (pH 8.0) buffer, and subjected to Ab measurement
with the use of a human Ab42 or Ab40 ELISA kit (Invitrogen) according to the
manufacturer’s instructions.
Behavioral Experiments
For behavioral analysis of Dp35KI and WT mice, we used 8-week-old males.
For analysis of WT, 5XFAD, Dp35KI, and 5XFAD;Dp35KI mice, we used 6- to
7-month-old males. Mice were handled more than 3 days before each behav-
ioral test.
Electrophysiology
For analysis ofDp35KImice and theirWT littermates, we used 2- to 3-week-old
males for LTD experiments, and 3- to 4-week-old males for LTP or intracellular
recordings. We used 6- to 7-month-old males for analysis of WT, 5XFAD,
Dp35KI, and 5XFAD;Dp35KI mice.
Statistics
Statistical analyses were performed using JMP Pro 10. ANOVAs followed by
Tukey’s post hoc analyses or unpaired Student’s t tests were used. All data
are represented as mean ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and two tables and can be foundwith this article online at http://dx.doi.
org/10.1016/j.cell.2014.01.065.
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Gräff, J., Rei, D., Guan, J.-S., Wang, W.-Y., Seo, J., Hennig, K.M., Nieland,
T.J.F., Fass, D.M., Kao, P.F., Kahn, M., et al. (2012). An epigenetic blockade
of cognitive functions in the neurodegenerating brain. Nature 483, 222–226.
Guan, J.-S., Haggarty, S.J., Giacometti, E., Dannenberg, J.-H., Joseph, N.,
Gao, J., Nieland, T.J.F., Zhou, Y., Wang, X., Mazitschek, R., et al. (2009).
HDAC2 negatively regulates memory formation and synaptic plasticity. Nature
459, 55–60.Guan, J.-S., Su, S.C., Gao, J., Joseph, N., Xie, Z., Zhou, Y., Durak, O., Zhang,
L., Zhu, J.J., Clauser, K.R., et al. (2011). Cdk5 is required for memory function
and hippocampal plasticity via the cAMP signaling pathway. PLoS ONE 6,
e25735.
Halpain, S., Girault, J.A., and Greengard, P. (1990). Activation of NMDA recep-
tors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature 343,
369–372.
Hemmings, H.C., Jr., Greengard, P., Tung, H.Y., and Cohen, P. (1984).
DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhib-
itor of protein phosphatase-1. Nature 310, 503–505.
Jawhar, S., Trawicka, A., Jenneckens, C., Bayer, T.A., and Wirths, O. (2012).
Motor deficits, neuron loss, and reduced anxiety coinciding with axonal
degeneration and intraneuronal Ab aggregation in the 5XFAD mouse model
of Alzheimer’s disease. Neurobiol. Aging 33, 196.e29–40.
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T.,
Sisodia, S., and Malinow, R. (2003). APP processing and synaptic function.
Neuron 37, 925–937.
Kesavapany, S., Zheng, Y.-L., Amin, N., and Pant, H.C. (2007). Peptides
derived from Cdk5 activator p35, specifically inhibit deregulated activity of
Cdk5. Biotechnol. J. 2, 978–987.
Kim, S.H., and Ryan, T.A. (2010). CDK5 serves as a major control point in
neurotransmitter release. Neuron 67, 797–809.
Kim, Y., Sung, J.Y., Ceglia, I., Lee, K.-W., Ahn, J.-H., Halford, J.M., Kim, A.M.,
Kwak, S.P., Park, J.B., Ho Ryu, S., et al. (2006). Phosphorylation of WAVE1
regulates actin polymerization and dendritic spine morphology. Nature 442,
814–817.
Kim, J., Lee, S., Park, K., Hong, I., Song, B., Son, G., Park, H., Kim, W.R., Park,
E., Choe, H.K., et al. (2007). Amygdala depotentiation and fear extinction.
Proc. Natl. Acad. Sci. USA 104, 20955–20960.
Kimura, R., and Ohno, M. (2009). Impairments in remote memory stabilization
precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer
mouse model. Neurobiol. Dis. 33, 229–235.
Ko, J., Humbert, S., Bronson, R.T., Takahashi, S., Kulkarni, A.B., Li, E., and
Tsai, L.H. (2001). p35 and p39 are essential for cyclin-dependent kinase 5
function during neurodevelopment. J. Neurosci. 21, 6758–6771.
Kuchibhotla, K.V., Goldman, S.T., Lattarulo, C.R., Wu, H.-Y., Hyman, B.T., and
Bacskai, B.J. (2008). Abeta plaques lead to aberrant regulation of calcium ho-
meostasis in vivo resulting in structural and functional disruption of neuronal
networks. Neuron 59, 214–225.
Lee, H.K., Kameyama, K., Huganir, R.L., and Bear, M.F. (1998). NMDA induces
long-term synaptic depression and dephosphorylation of the GluR1 subunit of
AMPA receptors in hippocampus. Neuron 21, 1151–1162.
Lee, H.K., Barbarosie, M., Kameyama, K., Bear, M.F., and Huganir, R.L.
(2000a). Regulation of distinct AMPA receptor phosphorylation sites during
bidirectional synaptic plasticity. Nature 405, 955–959.
Lee, M.S., Kwon, Y.T., Li, M., Peng, J., Friedlander, R.M., and Tsai, L.H.
(2000b). Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature
405, 360–364.
Lee, S.-H., Choi, J.-H., Lee, N., Lee, H.-R., Kim, J.-I., Yu, N.-K., Choi, S.-L.,
Lee, S.-H., Kim, H., and Kaang, B.-K. (2008). Synaptic protein degradation
underlies destabilization of retrieved fear memory. Science 319, 1253–1256.
Li, Z., Jo, J., Jia, J.-M., Lo, S.-C., Whitcomb, D.J., Jiao, S., Cho, K., and Sheng,
M. (2010). Caspase-3 activation via mitochondria is required for long-term
depression and AMPA receptor internalization. Cell 141, 859–871.
Li, S., Jin, M., Koeglsperger, T., Shepardson, N.E., Shankar, G.M., and Selkoe,
D.J. (2011). Soluble Ab oligomers inhibit long-term potentiation through a
mechanism involving excessive activation of extrasynaptic NR2B-containing
NMDA receptors. J. Neurosci. 31, 6627–6638.
Lu, W., Man, H., Ju, W., Trimble, W.S., MacDonald, J.F., and Wang, Y.T.
(2001). Activation of synaptic NMDA receptors induces membrane insertion
of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron
29, 243–254.Cell 157, 486–498, April 10, 2014 ª2014 Elsevier Inc. 497
Mitra, A., Mitra, S.S., and Tsien, R.W. (2012). Heterogeneous reallocation of
presynaptic efficacy in recurrent excitatory circuits adapting to inactivity.
Nat. Neurosci. 15, 250–257.
Mukerjee, N., McGinnis, K.M., Park, Y.H., Gnegy, M.E., andWang, K.K. (2000).
Caspase-mediated proteolytic activation of calcineurin in thapsigargin-medi-
ated apoptosis in SH-SY5Y neuroblastoma cells. Arch. Biochem. Biophys.
379, 337–343.
Mulkey, R.M., Herron, C.E., and Malenka, R.C. (1993). An essential role for
protein phosphatases in hippocampal long-term depression. Science 261,
1051–1055.
Mulkey, R.M., Endo, S., Shenolikar, S., and Malenka, R.C. (1994). Involvement
of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term
depression. Nature 369, 486–488.
Oakley, H., Cole, S.L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bon-
gaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006). Intraneuronal
beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic
mice with five familial Alzheimer’s disease mutations: potential factors in
amyloid plaque formation. J. Neurosci. 26, 10129–10140.
Ohshima, T., Ogura, H., Tomizawa, K., Hayashi, K., Suzuki, H., Saito, T.,
Kamei, H., Nishi, A., Bibb, J.A., Hisanaga, S.-I., et al. (2005). Impairment of hip-
pocampal long-term depression and defective spatial learning and memory in
p35 mice. J. Neurochem. 94, 917–925.
Otth, C., Concha, I.I., Arendt, T., Stieler, J., Schliebs, R., González-Billault, C.,
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